Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: The seed and soil also needs "fertilizer"

Cell Cycle

Volumn 10, Issue 15, 2011, Pages 2440-2449

  Lisanti, Michael P ^a,b,c   Martinez Outschoorn, Ubaldo E ^a,b   Lin, Zhao ^a,b   Pavlides, Stephanos ^a,b   Whitaker Menezes, Diana ^a,b   Pestell, Richard G ^a,b   Howell, Anthony ^c   Sotgia, Federica ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aging; Autophagy; Cancer metabolism; DNA damage; HIF1; Hydrogen peroxide; Hypoxia; Inflammation; Microenvironment; NF B; Oxidative stress; Seed and soil hypothesis; Tumor stroma

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AGING; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; DNA DAMAGE; FIBROBLAST; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; METASTASIS; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; REVIEW; TUMOR MICROENVIRONMENT;

EID: 79961111552     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.15.16870     Document Type: Review

References (139)

1. Woo DK, Shadel GS. Mitochondrial stress signals revise an old aging theory. Cell 2011; 144:11-2; PMID: 21215364; DOI: 10.1016/j.cell.2010.12.023.
2. Treiber N, Maity P, Singh K, Kohn M, Keist AF, Ferchiu F, et al. Accelerated aging phenotype in mice with conditional deficiency for mitochondrial superoxide dismutase in the connective tissue. Aging Cell 2011; 10:239-54; PMID: 21108731; DOI: 10.1111/j.1474-9726.2010.00658.x.
3. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308:1909-11; PMID: 15879174; DOI: 10.1126/science.1106653.
4. Gil Del Valle L. Oxidative stress in aging: Theoretical outcomes and clinical evidences in humans. Biomed Pharmacother 2011; In press.
5. Blagosklonny MV. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal. Cell Cycle 2010; 9:4788-94; PMID: 21150328; DOI: 10.4161/cc.9.24.14360.
6. Blagosklonny MV, Campisi J, Sinclair DA. Aging: past, present and future. Aging (Albany NY) 2009; 1:1-5; PMID: 20157590.
7. Hole PS, Pearn L, Tonks AJ, James PE, Burnett AK, Darley RL, et al. Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34+ hematopoietic progenitor cells. Blood 2010; 115:1238-46; PMID: 20007804; DOI: 10.1182/blood-2009-06-222869.
8. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51:794-8; PMID: 1846317.
9. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18:775-94; PMID: 7750801; DOI: 10.1016/0891-5849(94)00198-S.
10. Feng Y, Santoriello C, Mione M, Hurlstone A, Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 2010; 8:1000562; PMID: 21179501; DOI: 10.1371/journal.pbio.1000562.
11. Alexandrova AY, Kopnin PB, Vasiliev JM, Kopnin BP. ROS upregulation mediates Ras-induced changes of cell morphology and motility. Exp Cell Res 2006; 312:2066-73; PMID: 16624288; DOI: 10.1016/j.yexcr.2006.03.004.
12. Martin KR, Saulnier MJ, Kari FW, Barrett JC, French JE. Timing of supplementation with the antioxidant N-acetyl-L-cysteine reduces tumor multiplicity in novel, cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) transgenic mice but has no impact on malignant progression. Nutr Cancer 2002; 43:59-66; PMID: 12467136; DOI: 10.1207/S15327914NC431-7.
13. Havre PA, O'Reilly S, McCormick JJ, Brash DE. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine. Cancer Res 2002; 62:1443-9; PMID: 11888918.
14. Kim JH, Park SH, Park SG, Choi JS, Xia Y, Sung JH. The Pivotal Role of Reactive Oxygen Species Generation in the Hypoxia-Induced Stimulation of Adipose-Derived Stem Cells. Stem Cells Dev 2011; In press.
15. Grek CL, Townsend DM, Tew KD. The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies. Pharmacol Ther 2011; 129:172-84; PMID: 20951732; DOI: 10.1016/j.pharmthera.2010.09.008.
16. Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009; 459:996-9; PMID: 19494811; DOI: 10.1038/nature08119.
17. Toullec A, Gerald D, Despouy G, Bourachot B, Cardon M, Lefort S, et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2010; 2:211-30; PMID: 20535745; DOI: 10.1002/emmm.201000073.
18. Waghray M, Cui Z, Horowitz JC, Subramanian IM, Martinez FJ, Toews GB, et al. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J 2005; 19:854-6; PMID: 15857893.
19. Kobayashi Y, Nishikawa M, Hyoudou K, Yamashita F, Hashida M. Hydrogen peroxide-mediated nuclear factor kappaB activation in both liver and tumor cells during initial stages of hepatic metastasis. Cancer Sci 2008; 99:1546-52; PMID: 18754865; DOI: 10.1111/j.1349-7006.2008.00856.x.
20. Dai DF, Rabinovitch P. Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts. Autophagy 2011; 7:917-8;PMID: 21505274.
21. Roszkowski K, Jozwicki W, Blaszczyk P, Mucha-Malecka A, Siomek A. Oxidative damage DNA: 8-oxoGua and 8-oxodG as molecular markers of cancer. Med Sci Monit 2011; 17:329-33; PMID: 21629187.
22. Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, et al. HIF1alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010; 9:3534-51; PMID: 20864819; DOI: 10.4161/cc.9.17.12908.
23. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010; 9:3256-76; PMID: 20814239; DOI: 10.4161/cc.9.16.12553.
24. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010; 9:3515-33; PMID: 20855962; DOI: 10.4161/cc.9.17.12928.
25. Lisanti MP, Martinez-Outschoorn UE, Chiavarina B, Pavlides S, Whitaker-Menezes D, Tsirigos A, et al. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor microenvironment. Cancer Biol Ther 2011; 10:537-42; PMID: 20861671; DOI: 10.4161/cbt.10.6.13370.
26. Vincent AS, Phan TT, Mukhopadhyay A, Lim HY, Halliwell B, Wong KP. Human skin keloid fibroblasts display bioenergetics of cancer cells. J Invest Dermatol 2008; 128:702-9; PMID: 17943178; DOI: 10.1038/sj.jid.5701107.
27. De Felice B, Garbi C, Santoriello M, Santillo A, Wilson RR. Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts. Mol Cell Biochem 2009; 327:191-201; PMID: 19224335; DOI: 10.1007/s11010-009-0057-x.
28. Ueda K, Yasuda Y, Furuya E, Oba S. Inadequate blood supply persists in keloids. Scand J Plast Reconstr Surg Hand Surg 2004; 38:267-71; PMID: 15513596; DOI: 10.1080/02844310410029552.
29. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124:269-70; PMID: 13351639.
30. Warburg O. On the origin of cancer cells. Science 1956; 123:309-14; PMID: 13298683; DOI: 10.1126/science.123.3191.309.
31. Sieweke MH, Bissell MJ. The tumor-promoting effect of wounding: a possible role for TGFbeta-induced stromal alterations. Crit Rev Oncog 1994; 5:297-311; PMID: 7849089.
32. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3:453-8; PMID: 12778135; DOI: 10.1038/nrc1098.
33. Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 2010; 70:5649-69; PMID: 20610625; DOI: 10.1158/0008-5472.CAN-10-1040.
34. Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 2007; 26:705-15; PMID: 17786535; DOI: 10.1007/s10555-007-9088-5.
35. Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, et al. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the reverse Warburg effect: Implications for PET imaging of human tumors. Cell Cycle 2011; 10; In press.
36. Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: Role of stromal caveolin-1 as a key regulator. Cell Cycle 2011; 10:1784-93; PMID: 21566463.
37. Witkiewicz AK, Kline J, Queenan M, Brody JR, Tsirigos A, Bilal E, et al. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers. Cell Cycle 2011; 10:1794-809; PMID: 21521946.
38. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10:1772-83; PMID: 21558814.
39. Kasapovic J, Pejic S, Stojiljkovic V, Todorovic A, Radosevic-Jelic L, Saicic ZS, et al. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clin Biochem 2010; 43:1287-93; PMID: 20713039; DOI: 10.1016/j.clinbiochem.2010.08.009.
40. Ishii K, Zhen LX, Wang DH, Funamori Y, Ogawa K, Taketa K. Prevention of mammary tumorigenesis in acatalasemic mice by vitamin E supplementation. Jpn J Cancer Res 1996; 87:680-4; PMID: 8698615.
41. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, et al. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005; 68:1018-31; PMID: 16105032; DOI: 10.1111/j.1523-755.2005.00494.x.
42. Sunami R, Sugiyama H, Wang DH, Kobayashi M, Maeshima Y, Yamasaki Y, et al. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol 2004; 286:1030-8; PMID: 14722014; DOI: 10.1152/ajprenal.00266. 2003.
43. Fukuoka N, Sugiyama H, Inoue T, Kikumoto Y, Takiue K, Morinaga H, et al. Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Am J Nephrol 2008; 28:661-8; PMID: 18337633; DOI: 10.1159/000121357.
44. Odajima N, Betsuyaku T, Nagai K, Moriyama C, Wang DH, Takigawa T, et al. The role of catalase in pulmonary fibrosis. Respir Res 2010; 11:183; PMID: 21190578; DOI: 10.1186/1465-9921-11-183.
45. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162:943-52; PMID: 16192345; DOI: 10.1093/aje/kwi306.
46. Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, et al. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2011; 20:262-71; PMID: 21177425; DOI: 10.1158/1055-9965.EPI-10-1072.
47. Hyoudou K, Nishikawa M, Ikemura M, Kobayashi Y, Mendelsohn A, Miyazaki N, et al. Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase. J Control Release 2009; 137:110-5; PMID: 19361547; DOI: 10.1016/j.jconrel.2009.04.005.
48. Hyoudou K, Nishikawa M, Kobayashi Y, Umeyama Y, Yamashita F, Hashida M. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 2006; 41:1449-58; PMID: 17023272; DOI: 10.1016/j. freeradbiomed.2006.08.004.
49. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett 2008; 266:53-9; PMID: 18362051; DOI: 10.1016/j.canlet.2008.02.031.
50. Nishikawa M, Hashida M. Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opin Drug Deliv 2006; 3:355-69; PMID: 16640496; DOI: 10.1517/17425247.3.3.355.
51. Nishikawa M, Hashida M, Takakura Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev 2009; 61:319-26; PMID: 19385054; DOI: 10.1016/j.addr.2009.01.001.
52. Nishikawa M, Tamada A, Hyoudou K, Umeyama Y, Takahashi Y, Kobayashi Y, et al. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 2004; 21:213-21; PMID: 15387371; DOI: 10.1023/B:CLIN.0000037706.13747.5e.
53. Nishikawa M, Tamada A, Kumai H, Yamashita F, Hashida M. Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer 2002; 99:474-9; PMID: 11992420; DOI: 10.1002/ijc.10387.
54. Goh J, Enns L, Fatemie S, Hopkins H, Morton J, Pettan-Brewer C, et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 2011; 11:191; PMID: 21605372; DOI: 10.1186/1471-2407-11-191.
55. Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial Oxidative Stress Drives Tumor Progression and Metastasis: Should We Use Antioxidants As A Key Component of Cancer Treatment and Prevention? BMC Med 2011; 9:62; PMID: 21605374; DOI: 10.1186/1741-7015-9-62.
56. Brigelius-Flohe R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 2009; 1790:1555-68.
57. Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg 2011; 74:4-8; PMID: 21563647.
58. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol 2010; 117:5-10; PMID: 20304221; DOI: 10.1016/j.ygyno.2010.01.024.
59. Singhi AD, Califano J, Westra WH. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2011; In press.
60. Yu KJ, Hsu WL, Pfeiffer RM, Chiang CJ, Wang CP, Lou PJ, et al. Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clin Cancer Res 2011; 17:1906-14; PMID: 21447725; DOI: 10.1158/1078-0432.CCR-10-1681.
61. Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP, et al. Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancer 2011; 117:618-24; PMID: 20886634; DOI: 10.1002/cncr.25616.
62. Handa O, Naito Y, Yoshikawa T. Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Rep 2011; 16:1-7; PMID: 21605492; DOI: 10.1179/174329211X12968219310756.
63. Qian N, Ueno T. Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies? Arch Med Res 2010; 41:297-301; PMID: 20637375; DOI: 10.1016/j.arcmed.2010.05.009.
64. Thorsteinsdottir S, Gudjonsson T, Nielsen OH, Vainer B, Seidelin JB. Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis. Nat Rev Gastroenterol Hepatol 2011; 8:395-404.
65. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 2011; 208:417-20; PMID: 21357740; DOI: 10.1084/jem.20110367.
66. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res 2008; 68:9909-17; PMID: 19047172; DOI: 10.1158/0008-5472.CAN-08-1551.
67. Merliss RR. Talc-treated rice and Japanese stomach cancer. Science 1971; 173:1141-2; PMID: 5098957; DOI: 10.1126/science.173.4002.1141.
68. Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 2010; 9:2423-33; PMID: 20562526; DOI: 10.4161/cc.9.12.12048.
69. Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, et al. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: Achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011; 10:1271-86; PMID: 21512313; DOI: 10.4161/cc.10.8.15330.
70. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, et al. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010; 9:3506-14; PMID: 20818174; DOI: 10.4161/cc.9.17.12731.
71. Pavlides S, Tsirigos A, Migneco G, Whitaker- Menezes D, Chiavarina B, Flomenberg N, et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010; 9:3485-505; PMID: 20861672; DOI: 10.4161/cc.9.17.12721.
72. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": A transcriptional informatics analysis with validation. Cell Cycle 2010; 9:2201-19; PMID: 20519932; DOI: 10.4161/cc.9.11.11848.
73. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease and "Neuron-Glia Metabolic Coupling". Aging (Albany NY) 2010; 2:185-99; PMID: 20442453.
74. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8:3984-4001; PMID: 19923890; DOI: 10.4161/cc.8.23.10238.
75. Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: Evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010; 9:2412-22; PMID: 20562527; DOI: 10.4161/cc.9.12.11989.
76. Zhang GY, Yu Q, Cheng T, Liao T, Nie CL, Wang AY, et al. Role of caveolin-1 in the pathogenesis of tissue fibrosis by keloid-derived fibroblasts in vitro. Br J Dermatol 2011; 164:623-7; PMID: 21375514.
77. Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, Martinez-Outschoorn UE, et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 2011; 11:383-94; PMID: 21150282; DOI: 10.4161/cbt.11.4.14101.
78. Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, et al. The reverse Warburg effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010; 9:1960-71; PMID: 20495363; DOI: 10.4161/cc.9.10.11601.
79. Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet R, Eaton G, Martinez-Outschoorn UE, et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: A new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 2011; 11:383-94; PMID: 21150282; DOI: 10.4161/cbt.11.4.14101.
80. Xie L, Pandey R, Xu B, Tsaprailis G, Chen QM. Genomic and proteomic profiling of oxidative stress response in human diploid fibroblasts. Biogerontology 2009; 10:125-51; PMID: 18654835; DOI: 10.1007/s10522-008-9157-3.
81. Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, et al. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle 2009; 8:1654-8; PMID: 19448435; DOI: 10.4161/cc.8.11.8544.
82. Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, et al. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biol Ther 2009; 8:1071-9; PMID: 19502809; DOI: 10.4161/cbt.8.11.8874.
83. Witkiewicz AK, Dasgupta A, Sammons S, Er O, Potoczek MB, Guiles F, et al. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 2010; 10:135-43; PMID: 20431349; DOI: 10.4161/cbt.10.2.11983.
84. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009; 174:2023-34; PMID: 19411448; DOI: 10.2353/ajpath.2009.080873.
85. Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, Henderson MA, et al. Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 2009; 174:2035-43; PMID: 19411449; DOI: 10.2353/ajpath.2009.080924.
86. Koo JS, Park S, Kim SI, Lee S, Park BW. The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer. Tumour Biol 2011; In press; PMID: 21584795; DOI: 10.1007/s13277-011-0181-6.
87. Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, Mikami Y, et al. Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci 2011; In press; PMID: 21585620; DOI: 10.1111/j.1349-7006.2011.01985.x.
88. Ghajar CM, Meier R, Bissell MJ. Quis custodiet ipsos custodies: who watches the watchmen? Am J Pathol 2009; 174:1996-9; PMID: 19465642; DOI: 10.2353/ajpath.2009.090363.
89. Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 2009; 8:2420-4; PMID: 19556867; DOI: 10.4161/cc.8.15.9116.
90. Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et al. The Autophagic Tumor Stroma Model of Cancer or "Battery-Operated Tumor Growth": A Simple Solution to the Autophagy Paradox. Cell Cycle 2010; 9:4297-306; PMID: 21051947; DOI: 10.4161/cc.9.21. 13817.
91. Brooks GA. The lactate shuttle during exercise and recovery. Med Sci Sports Exerc 1986; 18:360-8; PMID: 3523107; DOI: 10.1249/00005768-198606000- 00019.
92. Bittar PG, Charnay Y, Pellerin L, Bouras C, Magistretti PJ. Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab 1996; 16:1079-89; PMID: 8898679; DOI: 10.1097/00004647-199611000-00001.
93. Laughton JD, Bittar P, Charnay Y, Pellerin L, Kovari E, Magistretti PJ, et al. Metabolic compartmentalization in the human cortex and hippocampus: evidence for a cell- and region-specific localization of lactate dehydrogenase 5 and pyruvate dehydrogenase. BMC Neurosci 2007; 8:35; PMID: 17521432; DOI: 10.1186/1471-2202-8-35.
94. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders. Ann NY Acad Sci 1996; 777:380-7; PMID: 8624117; DOI: 10.1111/j.1749-6632.1996.tb34449.x.
95. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16:877-85; PMID: 8558256.
96. Biggers JD, Whittingham DG, Donahue RP. The pattern of energy metabolism in the mouse oocyte and zygote. Proc Natl Acad Sci USA 1967; 58:560-7; PMID: 5233459; DOI: 10.1073/pnas.58.2.560.
97. Brinster RL. Oxidation of pyruvate and glucose by oocytes of the mouse and rhesus monkey. J Reprod Fertil 1971; 24:187-91; PMID: 4994572; DOI: 10.1530/jrf.0.0240187.
98. Colonna R, Cecconi S, Buccione R, Mangia F. Amino acid transport systems in growing mouse oocytes. Cell Biol Int Rep 1983; 7:1007-15; PMID: 6667499; DOI: 10.1016/0309-1651(83)90005-X.
99. Colonna R, Mangia F. Mechanisms of amino acid uptake in cumulus-enclosed mouse oocytes. Biol Reprod 1983; 28:797-803; PMID: 6860738; DOI: 10.1095/biolreprod28.4.797.
100. Su YQ, Sugiura K, Eppig JJ. Mouse oocyte control of granulosa cell development and function: paracrine regulation of cumulus cell metabolism. Semin Reprod Med 2009; 27:32-42; PMID: 19197803; DOI: 10.1055/s-0028-1108008.
101. Su YQ, Sugiura K, Wigglesworth K, O'Brien MJ, Affourtit JP, Pangas SA, et al. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development 2008; 135:111-21; PMID: 18045843; DOI: 10.1242/dev.009068.
102. Sugiura K, Pendola FL, Eppig JJ. Oocyte control of metabolic cooperativity between oocytes and companion granulosa cells: energy metabolism. Dev Biol 2005; 279:20-30; PMID: 15708555; DOI: 10.1016/j.ydbio.2004.11.027.
103. Sugiura K, Su YQ, Diaz FJ, Pangas SA, Sharma S, Wigglesworth K, et al. Oocyte-derived BMP15 and FGFs cooperate to promote glycolysis in cumulus cells. Development 2007; 134:2593-603; PMID: 17553902; DOI: 10.1242/dev.006882.
104. Sugiura K, Su YQ, Li Q, Wigglesworth K, Matzuk MM, Eppig JJ. Fibroblast growth factors and epidermal growth factor cooperate with oocyte-derived members of the TGFbeta superfamily to regulate Spry2 mRNA levels in mouse cumulus cells. Biol Reprod 2009; 81:833-41; PMID: 19553596; DOI: 10.1095/biolreprod.109. 078485.
105. Anderson EJ, Neufer PD. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am J Physiol Cell Physiol 2006; 290:844-51; PMID: 16251473; DOI: 10.1152/ajpcell.00402.2005.
106. Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg A, Flomenberg N, Wang C, et al. Understanding the metabolic basis of drug resistance: Therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle 2011; 10; In press.
107. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 2008; 10:475-510; PMID: 18154485; DOI: 10.1089/ars.2007.1740.
108. López-Lázaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 2007; 252:1-8; PMID: 17150302; DOI: 10.1016/j.canlet.2006.10.029.
109. 2 from living cancer cells based on ZnO nanosheets. Anal Chim Acta 2010; 670:57-62; PMID: 20685417; DOI: 10.1016/j.aca.2010.04.065.
110. 2 level in exhaled breath condensate in primary breast cancer patients. J Cancer Res Clin Oncol 2010; 136:923-30; PMID: 19967414; DOI: 10.1007/s00432-009-0734-x.
111. Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009; 4:172-8; PMID: 19179892; DOI: 10.1097/JTO.0b013e3181949eb9.
112. Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009; 63:164-8; PMID: 18599152; DOI: 10.1016/j.lungcan.2008.05.020.
113. Psathakis K, Mermigkis D, Papatheodorou G, Loukides S, Panagou P, Polychronopoulos V, et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 2006; 36:362-7; PMID: 16634841; DOI: 10.1111/j.1365-2362.2006.01636.x.
114. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 2006; 203:2895-906; PMID: 17178917; DOI: 10.1084/jem.20061536.
115. Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Circulation 2006; 114:912-20; PMID: 16940204; DOI: 10.1161/CIRCULATIONAHA.106.634709.
116. Jasmin JF, Mercier I, Hnasko R, Cheung MW, Tanowitz HB, Dupuis J, et al. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovasc Res 2004; 63:747-55; PMID: 15306231; DOI: 10.1016/j.cardiores.2004.05.018.
117. Van de Bittner GC, Dubikovskaya EA, Bertozzi CR, Chang CJ. In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc Natl Acad Sci USA 2010; 107:21316-21; PMID: 21115844; DOI: 10.1073/pnas.1012864107.
118. Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multicenter study. Ann Nucl Med 2011; 25:355-64.
119. Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, et al. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med 2010; 51:1234-40; PMID: 20660384; DOI: 10.2967/jnumed.109.072371.
120. Glaudemans AW, Signore A. FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging 2010; 37:1986-91; PMID: 20700737; DOI: 10.1007/s00259-010-1587-x.
121. Tsuji AB, Morita M, Li XK, Sogawa C, Sudo H, Sugyo A, et al. 18F-FDG PET for semiquantitative evaluation of acute allograft rejection and immunosuppressive therapy efficacy in rat models of liver transplantation. J Nucl Med 2009; 50:827-30; PMID: 19372488; DOI: 10.2967/jnumed.108.058925.
122. Reuter S, Schnockel U, Edemir B, Schroter R, Kentrup D, Pavenstadt H, et al. Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency. J Nucl Med 2010; 51:1644-52; PMID: 20847180; DOI: 10.2967/jnumed.110.078550.
123. Reuter S, Schnockel U, Schroter R, Schober O, Pavenstadt H, Schafers M, et al. Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET. PLoS ONE 2009; 4:5296; PMID: 19390685; DOI: 10.1371/journal.pone.0005296.
124. Schnöckel U, Reuter S, Stegger L, Schlatter E, Schafers KP, Hermann S, et al. Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats. Eur J Nucl Med Mol Imaging 2008; 35:2267-74; PMID: 18622612; DOI: 10.1007/s00259-008-0878-y.
125. Kensese SM, Smith LL. Hydrogen peroxide mutagenicity towards Salmonella typhimurium. Teratog Carcinog Mutagen 1989; 9:211-8; PMID: 2572065; DOI: 10.1002/tcm.1770090404.
126. Naik S, Tredwin CJ, Scully C. Hydrogen peroxide tooth-whitening (bleaching): review of safety in relation to possible carcinogenesis. Oral Oncol 2006; 42:668-74; PMID: 16488181; DOI: 10.1016/j.oraloncology.2005.10.020.
127. Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK. Accumulation of oxidatively induced DNA damage in human breast cancer cell lines following treatment with hydrogen peroxide. Cell Cycle 2007; 6:1471-7; PMID: 17568196; DOI: 10.4161/cc.6.12.4301.
128. Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003; 417:3-11; PMID: 12921773; DOI: 10.1016/S0003-9861(03)00283-2.
129. Roh M, van der Meer R, Abdulkadir SA. Tumorigenic polyploid cells contain elevated ROS and are selectively targeted by antioxidant treatment. J Cell Physiol 2011; In press.
130. Graham KA, Kulawiec M, Owens KM, Li X, Desouki MM, Chandra D, et al. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther 2010; 10:223-31; PMID: 20523116; DOI: 10.4161/cbt.10.3.12207.
131. Du C, Gao Z, Venkatesha VA, Kalen AL, Chaudhuri L, Spitz DR, et al. Mitochondrial ROS and radiation induced transformation in mouse embryonic fibroblasts. Cancer Biol Ther 2009; 8:1962-71; PMID: 19738419; DOI: 10.4161/cbt.8.20.9648.
132. Uziel O, Reshef H, Ravid A, Fabian I, Halperin D, Ram R, et al. Oxidative stress causes telomere damage in Fanconi anaemia cells - a possible predisposition for malignant transformation. Br J Haematol 2008; 142:82-93; PMID: 18477050; DOI: 10.1111/j.1365-2141.2008.07137.x.
133. Pennisi E. Superoxides relay Ras protein's oncogenic message. Science 1997; 275:1567-8; PMID: 9072821; DOI: 10.1126/science.275.5306.1567.
134. Pervaiz S, Clement MV. Superoxide anion: oncogenic reactive oxygen species? Int J Biochem Cell Biol 2007; 39:1297-304; PMID: 17531522; DOI: 10.1016/j.biocel.2007.04.007.
135. Liu TY, Chen CL, Chi CW. Oxidative damage to DNA induced by areca nut extract. Mutat Res 1996; 367:25-31; PMID: 8596543; DOI: 10.1016/S0165-1218(96) 90018-X.
136. Nair UJ, Obe G, Friesen M, Goldberg MT, Bartsch H. Role of lime in the generation of reactive oxygen species from betel-quid ingredients. Environ Health Perspect 1992; 98:203-5; PMID: 1486850; DOI: 10.1289/ehp.9298203.
137. Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227:375-81; PMID: 2981433; DOI: 10.1126/science.2981433.
138. Jones GM, Sanford KK, Parshad R, Gantt R, Price FM, Tarone RE. Influence of added catalase on chromosome stability and neoplastic transformation of mouse cells in culture. Br J Cancer 1985; 52:583-90; PMID: 2415146; DOI: 10.1038/bjc.1985.230.
139. Lisanti MP, Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A, et al. Accelerated aging in the tumor microenvironment: Connecting aging, inflammation and cancer metabolism with personalized medicine. Cell Cycle 2011; 10:2059-63; PMID: 21654190.